Global X Genomics & Biotechnology ETF
GNOM
GNOM
60 hedge funds and large institutions have $67.2M invested in Global X Genomics & Biotechnology ETF in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
37% less capital invested
Capital invested by funds: $107M → $67.2M (-$40M)
Holders
60
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.36M | |
| 2 | +$2.3M | |
| 3 | +$1.59M | |
| 4 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
+$1.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$697K |
Top Sellers
| 1 | -$16.8M | |
| 2 | -$3.42M | |
| 3 | -$2.3M | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.41M |
| 5 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
-$1.34M |